- ICH GCP
- Yhdysvaltain kliinisten tutkimusten rekisteri
- Kliininen tutkimus NCT04881890
Low-Carbohydrate Diabetes Prevention Program Among Veterans With Prediabetes (VA LC-DPP)
A Mixed Methods Pilot Study of a Low-Carbohydrate Diabetes Prevention Program Among Veterans With Prediabetes
Tutkimuksen yleiskatsaus
Tila
Ehdot
Interventio / Hoito
Yksityiskohtainen kuvaus
The Veteran population faces high rates of T2DM with estimates surpassing 20% compared to 14% among the general population. Furthermore, an estimated 25% of overweight or obese Veterans have prediabetes and many will progress to T2DM over time. Fortunately, T2DM can be prevented or delayed through dietary and physical activity changes that promote weight loss of ≥5% body weight. To help Veterans lose weight and avoid obesity-related chronic conditions such as T2DM, the VA Health System offers a lifestyle change program, VA MOVE!. Although MOVE! is widely adopted across the VA Health System, weight loss outcomes are modest (range of 0.13-3.3 kg loss over one year) and less than 20% of participants achieve ≥5% weight loss.
Novel strategies are needed to help more Veterans to lose weight and prevent and manage obesity-related conditions. One promising approach may be through a low-carbohydrate dietary intervention. Consistent with historic United States Dietary Guidelines, diabetes prevention clinical trials and their translational group-based programs, including VA MOVE!, recommend a low-fat, calorie-restricted diet. However, the scientific merit of this recommendation has been criticized. Growing evidence supports the efficacy of low-carbohydrate diets (defined <26% total energy from carbohydrate per day) and VLCDs (defined as <10% of total energy from carbohydrate per day) for short-term weight loss, long-term weight maintenance, and improved glycemic control, particularly among individuals with T2DM and insulin resistance.
The objectives of this single-arm mixed methods pilot study are (1) to test the feasibility and acceptability of a low-carbohydrate Diabetes Prevention Program (LC-DPP) among Veterans with prediabetes and (2) to estimate weight loss among LC-DPP participants.
The investigators will recruit approximately 22 patients with body mass index ≥ 25 kg/m2 and prediabetes (defined as hemoglobin A1c [A1c] 5.7-6.4%). Participants will be identified by chart review and invited to participate by postal letter. Individuals that do not opt-out of study contact will be screened for eligibility by telephone call. Interested and eligible participants will be invited to attend an in-person information session. During this session, they will receive information about the dietary intervention; written informed consent will be obtained at this time. Study participants will attend a total of 24 group-based classes over the course of 1-year. Body weight will be measured at each session. At 0, 6, and 12-months, the investigators will measure hemoglobin A1c (HbA1c) and cholesterol levels as well as self-reported measures of quality of life, mood, hunger, cravings, and physical symptoms. Primary outcomes will be feasibility (e.g., enrollment, retention) and acceptability (e.g., session attendance, qualitative feedback). Secondary outcomes will change in weight, achievement of ≥5% body weight loss, change in HbA1c, and change in cholesterol levels. During semi-structured interviewed conducted at 6-months and 12-months, the investigators will explore participants' experiences with the program, barriers to and facilitators of adherence to a low-carbohydrate diet, and perspectives on ways to improve the intervention.
Opintotyyppi
Ilmoittautuminen (Todellinen)
Vaihe
- Ei sovellettavissa
Yhteystiedot ja paikat
Opiskelupaikat
-
-
Michigan
-
Ann Arbor, Michigan, Yhdysvallat, 48104
- Department of Veteran Affairs
-
-
Osallistumiskriteerit
Kelpoisuusvaatimukset
Opintokelpoiset iät
Hyväksyy terveitä vapaaehtoisia
Sukupuolet, jotka voivat opiskella
Kuvaus
Inclusion Criteria:
- Overweight, defined as BMI≥25 kg/m2 [31]
- HbA1c between 5.7-6.4% drawn within 1 year of the study start date
- Willingness to participate in group-based classes
- Able to engage in at least light physical activities such as walking.
Exclusion Criteria:
- History of type 1 diabetes or type 2 diabetes
- Current participation in another lifestyle or behavior change program or research study
- Vegetarian or vegan lifestyle
- History of bariatric surgery
- Inability to read, write, or speak English
- Inability to provide informed consent
- Women who are pregnant or intend to become pregnant during the intervention period.
Opintosuunnitelma
Miten tutkimus on suunniteltu?
Suunnittelun yksityiskohdat
- Ensisijainen käyttötarkoitus: Ennaltaehkäisy
- Jako: Ei käytössä
- Inventiomalli: Yksittäinen ryhmätehtävä
- Naamiointi: Ei mitään (avoin tarra)
Aseet ja interventiot
Osallistujaryhmä / Arm |
Interventio / Hoito |
---|---|
Kokeellinen: Low-Carbohydrate Diabetes Prevention Program
At least 20 individuals with prediabetes will participate in a year-long , group-based program.
|
LC-DPP participants will be instructed to follow ad-libitum very low-carbohydrate, ketogenic diet, which restricts carbohydrate intake (not including fiber) to 20-35 grams per day with the goal of achieving nutritional ketosis.
Participants will be encouraged to eat a normal amount of protein (roughly 80-120 grams per day) and to derive the remaining calories from fat.
Allowable foods include: meats, fish, poultry, eggs, cheese, seeds, nuts, leafy greens, non-starchy vegetables, and some fruits
|
Mitä tutkimuksessa mitataan?
Ensisijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
---|---|---|
Assess recruitment feasibility and interest in the study
Aikaikkuna: Baseline
|
This will be calculated by dividing by number of enrolled participants by the number of individuals invited to participate.
|
Baseline
|
Retention of participants in the study
Aikaikkuna: 6 months
|
Retention of participants in the study will be determined by the participant completion of surveys
|
6 months
|
Retention of participants in the study
Aikaikkuna: 12 months
|
Retention of participants in the study will be determined by the participant completion of surveys
|
12 months
|
Session attendance
Aikaikkuna: 6 months
|
Attendance will determined by the mean number meetings attended by each participant
|
6 months
|
Session attendance
Aikaikkuna: 12 months
|
Attendance will determined by the mean number meetings attended by each participant
|
12 months
|
Acceptability of the program by participants
Aikaikkuna: 6 month
|
Determined by semi-structured interview responses
|
6 month
|
Acceptability of the program by participants
Aikaikkuna: 12 month
|
Determined by semi-structured interview responses
|
12 month
|
Adherence with self-weighing
Aikaikkuna: 6 months
|
Calculated by dividing the number of self-reported weights by the number of sessions.
|
6 months
|
Adherence with self-weighing
Aikaikkuna: 12 months
|
Calculated by dividing the number of self-reported weights by the number of sessions.
|
12 months
|
Adherence with physical activity goals
Aikaikkuna: 6 months
|
Defined by participants that report at least 150 minutes of physical activity in a week.
|
6 months
|
Adherence with physical activity goals
Aikaikkuna: 12 months
|
Defined by participants that report at least 150 minutes of physical activity in a week.
|
12 months
|
Adherence with food tracking
Aikaikkuna: 6 months
|
Defined by participants that report maintaining a food log.
|
6 months
|
Adherence with food tracking
Aikaikkuna: 12 months
|
Defined by participants that report maintaining a food log.
|
12 months
|
Toissijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
---|---|---|
Change in physical activity measured using the International Physical Activity Questionnaire
Aikaikkuna: 6 months to baseline
|
Participants will complete this validated survey.
Minimum value: 0, Maximum Value: 9.
|
6 months to baseline
|
Change in physical activity measured using the International Physical Activity Questionnaire
Aikaikkuna: 12 months to baseline
|
Participants will complete this validated survey.
Minimum value: 0, Maximum Value: 9.
|
12 months to baseline
|
Change in food cravings measured using the Control of Eating Questionnaire
Aikaikkuna: 6 months to baseline
|
Participants will complete this validated survey.
Minimum value: 0, Maximum Value: 100.
|
6 months to baseline
|
Change in food cravings measured using the Control of Eating Questionnaire
Aikaikkuna: 12 months to baseline
|
Participants will complete this validated survey.
Minimum value: 0, Maximum Value: 100.
|
12 months to baseline
|
Change in stress eating measured using the Palatable Eating Motives Scale
Aikaikkuna: 6 months to baseline
|
Participants will complete this validated survey.
|
6 months to baseline
|
Change in stress eating measured using the Palatable Eating Motives Scale
Aikaikkuna: 12 months to baseline
|
Participants will complete this validated survey
|
12 months to baseline
|
Change in self-reported health measured using the Global Health PROMIS Questionnaire
Aikaikkuna: 6 months to baseline
|
Participants will complete this validated survey.
Minimum Value: 1. Maximum Value: 5.
The higher value indicated a more positive response.
|
6 months to baseline
|
Change in self-reported health measured using the Global Health PROMIS Questionnaire
Aikaikkuna: 12 months to baseline
|
Participants will complete this validated survey.
Minimum Value: 1. Maximum Value: 5.
The higher value indicated a more positive response.
|
12 months to baseline
|
Change in autonomous motivation measured using the Treatment Self-Regulation Questionnaire
Aikaikkuna: 6 months to baseline
|
Participants will complete this validated survey.
Minimum Value: 1. Maximum Value: 7. The higher value indicated a more positive response.
|
6 months to baseline
|
Change in autonomous motivation measured using the Treatment Self-Regulation Questionnaire
Aikaikkuna: 12 months to baseline
|
Participants will complete this validated survey.
Minimum Value: 1. Maximum Value: 7. The higher value indicated a more positive response.
|
12 months to baseline
|
Measured change in hemoglobin A1c
Aikaikkuna: 6 months to baseline
|
Measured using a laboratory blood draw
|
6 months to baseline
|
Measured change in hemoglobin A1c
Aikaikkuna: 12 months to baseline
|
Measured using a laboratory blood draw
|
12 months to baseline
|
Change in hemoglobin A1c
Aikaikkuna: 6 months to baseline
|
Baseline A1c will be subtracted from the 6 month A1c.
|
6 months to baseline
|
Change in hemoglobin A1c
Aikaikkuna: 12 months to baseline
|
Baseline A1c will be subtracted from the 12 month A1c.
|
12 months to baseline
|
Change in lipid levels
Aikaikkuna: 6 months to baseline
|
Baseline lipid levels will be subtracted from the 6 month lipid level.
|
6 months to baseline
|
Change in lipid levels
Aikaikkuna: 12 months to baseline
|
Baseline lipid levels will be subtracted from the 12 month lipid level.
|
12 months to baseline
|
Percentage of participants who achieve weight loss goal
Aikaikkuna: 6 month
|
Determined by the number of participants who lose at least 5% of their body weight during the study
|
6 month
|
Percentage of participants who achieve weight loss goal
Aikaikkuna: 12 month
|
Determined by the number of participants who lose at least 5% of their body weight during the study
|
12 month
|
Change in body weight per participant over the study period
Aikaikkuna: 6 months to baseline
|
Determined by subtracting the patients baseline weight from their weight at 6 months.
|
6 months to baseline
|
Change in body weight per participant over the study period
Aikaikkuna: 12 months to baseline
|
Determined by subtracting the patients baseline weight from their weight at 12 months.
|
12 months to baseline
|
Muut tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
---|---|---|
Change in physical symptoms
Aikaikkuna: 6 months to baseline
|
Participants will respond to exploratory survey questions about physical symptoms created by the study team.
|
6 months to baseline
|
Change in physical symptoms
Aikaikkuna: 12 months to baseline
|
Participants will respond to exploratory survey questions about physical symptoms created by the study team.
|
12 months to baseline
|
Yhteistyökumppanit ja tutkijat
Sponsori
Opintojen ennätyspäivät
Opi tärkeimmät päivämäärät
Opiskelun aloitus (Todellinen)
Ensisijainen valmistuminen (Todellinen)
Opintojen valmistuminen (Todellinen)
Opintoihin ilmoittautumispäivät
Ensimmäinen lähetetty
Ensimmäinen toimitettu, joka täytti QC-kriteerit
Ensimmäinen Lähetetty (Todellinen)
Tutkimustietojen päivitykset
Viimeisin päivitys julkaistu (Todellinen)
Viimeisin lähetetty päivitys, joka täytti QC-kriteerit
Viimeksi vahvistettu
Lisää tietoa
Tähän tutkimukseen liittyvät termit
Muita asiaankuuluvia MeSH-ehtoja
Muut tutkimustunnusnumerot
- LIP 20-122
Yksittäisten osallistujien tietojen suunnitelma (IPD)
Aiotko jakaa yksittäisten osallistujien tietoja (IPD)?
Lääke- ja laitetiedot, tutkimusasiakirjat
Tutkii yhdysvaltalaista FDA sääntelemää lääkevalmistetta
Tutkii yhdysvaltalaista FDA sääntelemää laitetuotetta
Nämä tiedot haettiin suoraan verkkosivustolta clinicaltrials.gov ilman muutoksia. Jos sinulla on pyyntöjä muuttaa, poistaa tai päivittää tutkimustietojasi, ota yhteyttä register@clinicaltrials.gov. Heti kun muutos on otettu käyttöön osoitteessa clinicaltrials.gov, se päivitetään automaattisesti myös verkkosivustollemme .
Kliiniset tutkimukset Prediabetes
-
Korea University Anam HospitalValmisPrediabetes (heikentynyt paastoglukoosi ja/tai heikentynyt glukoositoleranssi)
-
University of ZurichTuntematonPrediabetes / tyypin 2 diabetesSveitsi
-
George Mason UniversityEi vielä rekrytointiaSydän-ja verisuonitaudit | PrediabetesYhdysvallat
-
Laval UniversityCanadian Institutes of Health Research (CIHR)ValmisInsuliiniresistenssi | PrediabetesKanada
-
Northwestern UniversityRush UniversityValmisPrediabetes | VuorokausivaihteluYhdysvallat
-
Stanford UniversityRekrytointi
-
Gianna WilkieEi vielä rekrytointiaPrediabetes; Monimutkaista raskauttaYhdysvallat
-
New Mexico State UniversityEi vielä rekrytointia
-
University of BergenUniversity of Leipzig; Chalmers University of Technology; Nofima; Paderborn...ValmisHyperglykemia | Prediabetes | Glykeeminen hallinta | LeipääNorja
-
Memorial Hermann Health SystemTexas Academy of Family Physicians FoundationLopetettu
Kliiniset tutkimukset Low-Carbohydrate Diabetes Prevention Program
-
The University of Texas Medical Branch, GalvestonPeruutettuHypertensio | Prediabeettinen tila | Ylipaino tai liikalihavuus | Raskausajan painonnousu
-
Johns Hopkins UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Aktiivinen, ei rekrytointiHyperglykemia | Lihavuus | Ylipainoinen | Painonpudotus | Prediabetes | Prediabeettinen tila | Heikentynyt glukoosinsieto | Glukoosi, korkea verenpaine | Elämäntapa, terve | Elämäntyyliriskin vähentäminen | Elämäntapa, istumistaYhdysvallat
-
University of Kansas Medical CenterKansas State University; National Institute of General Medical Sciences...ValmisPainonpudotus | Prediabetes | Elämäntyyliriskin vähentäminenYhdysvallat
-
University of Mississippi Medical CenterAmerican Medical Association; Mississippi State Department of HealthAktiivinen, ei rekrytointiPrediabetes | Prediabeettinen tilaYhdysvallat
-
Indiana UniversityIndiana Clinical and Translational Sciences Institute; Regenstrief Institute... ja muut yhteistyökumppanitValmis
-
National Healthcare Group, SingaporeTan Tock Seng HospitalValmisDiabeettiset potilaat, pelimuotoilu, diabeetikkokasvatusSingapore
-
University of ArizonaValmis
-
Universiti Sultan Zainal AbidinTuntematonYlipaino ja lihavuus | Ennen diabetestaMalesia
-
NYU Langone HealthAmerican Diabetes AssociationRekrytointi
-
Northwestern UniversityWashington University School of MedicineRekrytointi